Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. 2008

Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA 94110, USA.

Circulating blood endothelial progenitor cells (EPCs) contribute to postnatal vasculogenesis, providing a novel therapeutic target for vascular diseases. However, the molecular mechanism of EPC-induced vasculogenesis is unknown. Interleukin-6 plays multiple functions in angiogenesis and vascular remodeling. Our previous study demonstrated that the polymorphism (174G>C) in IL-6 gene promoter was associated with brain vascular disease. In this study, we investigated if IL-6 receptor is expressed in human EPCs derived from circulating mononuclear cells, and if interleukin-6 (IL-6) stimulates EPC angiogenesis in vitro. First, we isolated and cultured mononuclear cells from adult human circulating blood. We obtained EPC clones that were further cultured and expended for the angiogenesis study. We found that the EPCs possessed human mature endothelial cell phenotypes; however, they proliferated much faster than mature endothelial cells (P<0.05). We then found that IL-6 receptor (gp-80) was expressed in the EPCs, and that administration of IL-6 could activate receptor gp80/gp130 signaling pathways including downstream extracellular signal-regulated kinase 1/2 and STAT3 phosphorylation in EPCs. Furthermore, IL-6 stimulated EPC proliferation, migration, and matrigel tube formation in a dose-dependent manner (P<0.05); anti-IL-6 antibodies or IL-6 receptor could abolish these effects (P<0.05). These results suggest that IL-6 plays a crucial role in the biologic behavior of blood-derived EPCs, which may help clarify the mechanism of IL-6 inflammatory-related diseases.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
August 2015, Cancer research,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
January 2021, Frontiers in cellular neuroscience,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
September 2017, Biology of reproduction,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
February 2014, BMC cancer,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
June 2011, Current stem cell research & therapy,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
December 2022, Journal of clinical and translational research,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
February 1995, Journal of endocrinological investigation,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
October 2002, Biochemical and biophysical research communications,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
January 2022, Frontiers in cellular neuroscience,
Yongfeng Fan, and Jianqin Ye, and Fanxia Shen, and Yiqian Zhu, and Yerem Yeghiazarians, and Wei Zhu, and Yongmei Chen, and Michael T Lawton, and William L Young, and Guo-Yuan Yang
April 1993, The American journal of pathology,
Copied contents to your clipboard!